Quarterly report · Q2
9438.TEDINET S100SBOM
Period2022-10-01 → 2023-03-31
Filed2023-11-20
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amends S100QQRZ.
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.6bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥26.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.0bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | −¥19m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥599m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥187m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥486m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥293m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥291m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥363m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥326m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥930m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥123m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥401m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥4m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥28.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥29.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥29.2bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.4bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.2bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.1bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥788m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥616m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥798m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥344m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥776m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.95 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.82 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.99 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.25 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.36 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥2.25 | 2021-10-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 46.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥793m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥793m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥1.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥9.5bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥9.4bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥89m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥2.8bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥5m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥220m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.4bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥699m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥807m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥461m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥14.4bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥13.6bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥793m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-03-31 | −¥646m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-03-31 | −¥646m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥1.2bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥9.0bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥112m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥2.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥10m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥649m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥2.5bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥524m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥176m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥121m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥121m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥233m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥13.6bn |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥13.0bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥646m |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 540
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss attributable to owners of parent | CurrentYTDDuration | -326160000 | JPY |
| Profit loss | Prior1YTDDuration | 3752000 | JPY |
| Profit loss | CurrentYTDDuration | -401022000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -20628000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | -1857000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 35342000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | -24879000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -1435000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | 1348000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | 30512000 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 35348000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 43791000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 9960000 | JPY |
| Comprehensive income | Prior1YTDDuration | 47543000 | JPY |
| Comprehensive income | CurrentYTDDuration | -391062000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 166511000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | -316199000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -118968000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -74862000 | JPY |
| Income before income taxes | Prior1YTDDuration | 362608000 | JPY |
| Income before income taxes | CurrentYTDDuration | 291414000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 694660000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 672354000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | 909000 | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 10546000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 109425000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 136177000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | 2564000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | -1282000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 65785000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 74142000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -65000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -52000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 2892000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 6135000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | 329690000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | -174973000 | JPY |
| Loss gain on step acquisitions ope cf | Prior1YTDDuration | 4700000 | JPY |
| Loss gain on step acquisitions ope cf | CurrentYTDDuration | － | JPY |
| Loss gain on change in equity ope cf | Prior1YTDDuration | -76481000 | JPY |
| Loss gain on change in equity ope cf | CurrentYTDDuration | -139531000 | JPY |
| Loss on retirement of noncurrent assets ope cf | Prior1YTDDuration | 10240000 | JPY |
| Loss on retirement of noncurrent assets ope cf | CurrentYTDDuration | 4105000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | 7148000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | -9176000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | 13450000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 191422000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -222549000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -91303000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |